Patent ID: 8367344

Claim:
A method of detecting leukemia, myeloproliferative diseases, myeloid tumors, and acute myeloid leukemia comprising the steps of: providing a hematopoietic cell line or a sample comprising hematopoietic cells; contacting the hematopoietic cell line or a sample comprising hematopoietic cells with an antibody which binds a biomarker for the cancerous disorders, wherein the biomarker is related to a component of interleukin 27 receptor; allowing the biomarker to bind to the antibody; and detecting the presence of the biomarker in said cell line or said sample using an immunoprotein assay; wherein the presence of the biomarker is indicative of leukemia, myeloproliferative diseases, myeloid tumors, and acute myeloid leukemia.